Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Flurbiprofen 8.75 mg Lozenge vs. Strepfen in Healthy Volunteers
NCT04670601Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Jun 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of flurbiprofen in pharyngitis (2 arms), sponsored by Angelini Pharma. Primary endpoints: Maximum Plasma Concentration and Area under the plasma concentration-time curve 0-t. Started Jun 2018; status: completed.
02
Drugs
flurbiprofen
03
Conditions
pharyngitis
Beyond the preview
Go deeper on NCT04670601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04670601.